| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.672 | 35.311 | 16.822 | 20.201 | 20.973 | 25.855 | 23.240 | 8.428 | - |
| Total Income - EUR | - | 22.672 | 36.219 | 16.872 | 20.201 | 20.973 | 25.855 | 23.240 | 8.428 | - |
| Total Expenses - EUR | - | 2.988 | 4.185 | 5.553 | 3.413 | 2.149 | 1.814 | 5.345 | 3.935 | - |
| Gross Profit/Loss - EUR | - | 19.684 | 32.034 | 11.319 | 16.788 | 18.825 | 24.041 | 17.895 | 4.493 | - |
| Net Profit/Loss - EUR | - | 19.004 | 30.947 | 10.813 | 16.182 | 18.195 | 23.265 | 17.197 | 3.720 | - |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Ldo Respimedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 979 | 577 | 3.699 | 2.210 | 1.548 | 372 | 0 | - |
| Current Assets | - | 19.612 | 30.320 | 10.449 | 12.780 | 16.219 | 29.745 | 55.002 | 3.762 | - |
| Inventories | - | 312 | 306 | 0 | 0 | 0 | 273 | 495 | 0 | - |
| Receivables | - | 2.966 | 3.127 | 674 | 3.271 | 598 | 0 | 20.829 | 126 | - |
| Cash | - | 16.335 | 26.887 | 9.775 | 9.509 | 15.621 | 29.472 | 33.678 | 3.636 | - |
| Shareholders Funds | - | 19.048 | 30.991 | 10.856 | 16.224 | 18.237 | 23.306 | 17.238 | 3.762 | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | - | 564 | 309 | 170 | 254 | 193 | 7.987 | 38.136 | 0 | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ldo Respimedica Srl